(Rockville, MD—September 17, 2001) The American Kidney Fund is pleased to announce a new nationwide program that will benefit thousands of low-income hemodialysis patients. Thanks to the generosity of Genzyme Corporation, AKF will launch its Renagel® Patient Assistance Program (RPAPSM) on September 17, 2001. This program will provide Renagel® 800 mg Tablets (sevelamer hydrochloride) to qualified patients who are referred by their nephrologists and social workers.
